Andrew Obenshain - Feb 10, 2025 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Feb 10, 2025
Transactions value $
$0
Form type
4
Date filed
2/12/2025, 04:13 PM
Previous filing
Feb 5, 2025
Next filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +763 +4.13% $0.00 19.2K Feb 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned from a performance stock unit (PSU) award granted to the Reporting Person on February 1, 2022, based on certain performance conditions. On February 9, 2025, the Compensation Committee of the Board of Directors determined that certain performance conditions have been satisfied.